114 related articles for article (PubMed ID: 9673790)
1. Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.
Ehrlich GK; Andria ML; Zheng X; Kieffer B; Gioannini TL; Hiller JM; Rosenkranz JE; Veksler BM; Zukin RS; Simon EJ
Can J Physiol Pharmacol; 1998 Mar; 76(3):269-77. PubMed ID: 9673790
[TBL] [Abstract][Full Text] [Related]
2. Selected cysteine residues in transmembrane domains of mu-opioid receptor are critical for effects of sulfhydryl reagents.
Deng HB; Guang W; Wang JB
J Pharmacol Exp Ther; 2000 Apr; 293(1):113-20. PubMed ID: 10734160
[TBL] [Abstract][Full Text] [Related]
3. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
4. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
Kokkola T; Salo OM; Poso A; Laitinen JT
J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
[TBL] [Abstract][Full Text] [Related]
5. Binding properties of C-truncated delta opioid receptors.
Wang CH; Zhou DH; Chen J; Li GE; Pei G; Chi ZQ
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):337-40. PubMed ID: 10072917
[TBL] [Abstract][Full Text] [Related]
6. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
[TBL] [Abstract][Full Text] [Related]
7. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
[TBL] [Abstract][Full Text] [Related]
8. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
[TBL] [Abstract][Full Text] [Related]
9. Functionality of the seventh and eighth transmembrane domains of acyl-coenzyme A:cholesterol acyltransferase 1.
Guo ZY; Chang CC; Chang TY
Biochemistry; 2007 Sep; 46(35):10063-71. PubMed ID: 17691824
[TBL] [Abstract][Full Text] [Related]
10. Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.
Claude-Geppert PA; Liu J; Solberg J; Erickson-Herbrandson LJ; Loh HH; Law PY
J Pharmacol Exp Ther; 2005 Apr; 313(1):216-26. PubMed ID: 15579496
[TBL] [Abstract][Full Text] [Related]
11. An aspartate residue at the extracellular boundary of TMII and an arginine residue in TMVII of the gastrin-releasing peptide receptor interact to facilitate heterotrimeric G protein coupling.
Donohue PJ; Sainz E; Akeson M; Kroog GS; Mantey SA; Battey JF; Jensen RT; Northup JK
Biochemistry; 1999 Jul; 38(29):9366-72. PubMed ID: 10413511
[TBL] [Abstract][Full Text] [Related]
12. Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.
Rezmann-Vitti LA; Nero TL; Jackman GP; Machida CA; Duke BJ; Louis WJ; Louis SN
J Med Chem; 2006 Jun; 49(12):3467-77. PubMed ID: 16759089
[TBL] [Abstract][Full Text] [Related]
13. A second disulfide bridge from the N-terminal domain to extracellular loop 2 dampens receptor activity in GPR39.
Storjohann L; Holst B; Schwartz TW
Biochemistry; 2008 Sep; 47(35):9198-207. PubMed ID: 18693759
[TBL] [Abstract][Full Text] [Related]
14. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
Javitch JA; Ballesteros JA; Weinstein H; Chen J
Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
[TBL] [Abstract][Full Text] [Related]
15. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
16. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
Lee SY; Zhu SZ; el-Fakahany EE
Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
[TBL] [Abstract][Full Text] [Related]
17. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
Qi LJ; Leung AT; Xiong Y; Marx KA; Abou-Samra AB
Biochemistry; 1997 Oct; 36(41):12442-8. PubMed ID: 9376348
[TBL] [Abstract][Full Text] [Related]
18. Leucine-2-alanine enkephalin induced delta opioid receptors internalization expressed stably in CHO cells.
Wang CH; Zhou DH; Chen J; Chi ZQ
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):491-4. PubMed ID: 10678138
[TBL] [Abstract][Full Text] [Related]
19. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein.
Horwitz AH; Leigh SD; Abrahamson S; Gazzano-Santoro H; Liu PS; Williams RE; Carroll SF; Theofan G
Protein Expr Purif; 1996 Aug; 8(1):28-40. PubMed ID: 8812832
[TBL] [Abstract][Full Text] [Related]
20. The role of individual cysteine residues in the processing, structure, and function of human macrophage colony-stimulating factor.
Deng P; Wang YL; Pattengale PK; Rettenmier CW
Biochem Biophys Res Commun; 1996 Nov; 228(2):557-66. PubMed ID: 8920951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
